TipRanks
Rapid Dose Therapeutics Corp (RDTCF)
OTHER OTC:RDTCF
US Market
RDTCF
Rapid Dose Therapeutics Corp
RESEARCH TOOLSreports

Rapid Dose Therapeutics Corp (RDTCF) Income Statement

0 Followers

Rapid Dose Therapeutics Corp Income Statement

Last quarter (Q4 2026), Rapid Dose Therapeutics Corp's total revenue was C$660.51K, a decrease of -15.62% from the same quarter last year. In Q4, Rapid Dose Therapeutics Corp's net income was C$-700.00K. See Rapid Dose Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 26May 25May 24Nov 22Feb 21
Total Revenue
C$ 2.77MC$ 2.09MC$ 1.02MC$ 718.30KC$ 755.20K
Gross Profit
C$ -956.89KC$ 1.18MC$ 563.41KC$ 372.40KC$ 699.85K
Operating Expenses
C$ 1.21MC$ -4.22MC$ 4.30MC$ 4.18MC$ 2.33M
Depreciation and Amortization
C$ 513.44KC$ 240.75KC$ 620.31KC$ 627.44KC$ 675.47K
EBITDA
C$ -1.66MC$ -3.93MC$ -3.02MC$ -2.92MC$ -987.00K
Operating Income
C$ -2.17MC$ 5.40MC$ -3.74MC$ -3.81MC$ -1.78M
Other Income/Expenses
C$ -1.22MC$ -10.81MC$ -568.00KC$ -1.61KC$ -28.04K
Pretax Income
C$ -3.39MC$ -5.40MC$ -4.31MC$ -3.81MC$ -1.80M
Net Income
C$ -3.39MC$ -5.40MC$ -4.31MC$ -3.81MC$ -1.80M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.04C$ -0.04C$ -0.04C$ -0.02
Diluted EPS
C$ -0.03C$ -0.04C$ -0.04C$ -0.04C$ -0.02
Weighted Average Shares Outstanding
 132.95M 124.57M 104.96M 103.42M 77.79M
Weighted Average Shares Outstanding (Diluted)
 132.95M 124.57M 104.96M 103.42M 77.79M
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History